GENOKS BY THE NUMBERS

15
Countries with Technology Collaboration
1000
Hospitals with Technology Partnership
8000
Physicians as Solution Partners
150000
NIPT Tests
250000
NGS Tests
1
Petabyte Database

Who We Are?

Genoks Genetic Diseases Evaluation Center, based in Ankara, is a genetic laboratory approved by the Ministry of Health.

Through Next-Generation Sequencing (NGS) technology for the diagnosis of genetic diseases NIPT, Exome, WES, carrier screening ve oncogenetic tests we provide reliable, fast and ethical solutions.

Through the technology transfers it has carried out ve and national–international collaborations , Genoks brings the world's most current molecular diagnostic methods to Turkey; it provides advanced technology support to institutions, physicians and patients across a broad range — from clinical genetic test services to research projects.

Genoks, alongside clinical test services focused on the diagnosis and evaluation of genetic diseases, provides technology and infrastructure support for scientific research .

Our institution operates on the principles of scientific accuracy, privacy and patient safety, and with its innovative infrastructure and expert team builds a bridge between genetic science and human health .

Our Vision is to strengthen the personalized medicine approach and to become Turkey's reference genetic diagnostic center .

Genoks Sağlık A.Ş. — Overview

Founded in 2008 as an R&D laboratory, Genoks developed PCR and RT-PCR based diagnostic kits and DNA isolation kits, producing solutions used by Turkey's leading institutes. Today with 1,100 m² of laboratory and office space, more than 100 specialist staff, and a collaboration network of 1,000+ centers in 15 countries and nearly 8,000 physicians it has evolved into a strong genomic analysis center. To date, over 250,000 NGS tests ve and more than 1 Pb of genetic data have been processed by Genoks; including NIPT, Whole Genome Sequencing, Whole Exome Sequencing, Cancer Genetics, Newborn and Carrier Screening , it offers comprehensive genetic diagnostic services and aims to be one of the leading genome centers in the EEMEA region.

Year Founded
2008
R&D origin, with a clinical genomics focus over 15 years of experience infrastructure built upon.
Headquarters
Ankara
Serving across Turkey and the surrounding region, a national reference genome laboratory in a central location.
Collaboration Network
15
15 countries, 1,000+ centers ve nearly 8,000 physicians sustained clinical collaboration and patient referral network.
Test and Data Volume
250.000+
250,000+ NGS tests, 1 Pb of genomic data and 150,000 NIPT applications providing a strong evidence-based experience pool.
 

Global reach and test volume

A scalable infrastructure that can address different clinical needs through both the number of centers and test experience.

15 Countries
10.000+ Headquarters
8000+ Collaborating physicians
250.000 NGS tests
1 Pb of genomic data
150.000 RapidNIPT tests

Quality management and accreditation

Test processes are regularly monitored and certified through national and international external quality programs.

EMQN
Molecular genetic analyses regularly evaluated in compliance with the European Molecular Genetics Quality Network external quality programs.
TÜRKAK
Documentation of competency and quality indicators of laboratory functions through processes conducted by the Turkish Accreditation Authority.
ISO 15189
A quality management system structured according to the ISO 15189 standard, which defines quality and competency requirements for medical laboratories.

Genoks TV

Our Vision and Mission

Genoks Genetic Diseases Evaluation Center, based on scientific reliability and ethical values, is a genetic test laboratory making a difference in genetic diagnostics. Our Vision to bring the innovations of genetic science to public health, improve individuals' quality of life, and become a reference genetic diagnostic center in Turkey .

Genoks adopts an innovative and sustainable health approach that offers solutions tailored to each individual's genetic profile. Our Mission is to provide scientifically valuable services to patients, physicians and researchers with accurate, reliable and fast results. In this direction, Next-Generation Sequencing (NGS) we contribute to the early diagnosis of genetic diseases and support the personalized medicine approach by using these technologies.

In every testing process we keep patient safety, privacy and quality at the forefront. Adhering to international quality standards, we act without compromising our ethical responsibilities. Genoks continues its journey with the vision of being an institution that bridges genetic science and human health.